Intervention

Copper Cu 64 TP3805

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions6

Lead sponsors shown1

Clinical trials

3 shown

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSANCT02989623 · 2015-09-01

COMPLETED

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing SurgeryNCT02603965 · 2013-08-01

COMPLETED

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast CancerNCT02810873 · 2008-09-01

TERMINATED

Common conditions

Breast Carcinoma1 Prostate Adenocarcinoma1 Prostate Cancer1 Stage IIB Prostate Cancer1 Stage III Prostate Cancer1 Stage IV Prostate Cancer1

Leading sponsors

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 3

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

NA2

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.